• Latest Posts
More News! 2 Feb 2017

Galapagos kicks off a Phase IIa trial for Cystic Fibrosis

Shire sells its RNA platform to a US-based Biotech

One Step Closer to the First Triple Combination Therapy for Cystic Fibrosis

Galapagos and AbbVie expand their Cystic Fibrosis collaboration

After a Deal with Gilead, Galapagos is Still Doing Phase II Trials with AbbVie

Fixing the ‘Galapagos-AbbVie Disaster’ through a Cystic Fibrosis Therapy

ADVERTISEMENT

First Success for Imperial Innovations’ Gene Therapy in Cystic Fibrosis

ProQR Therapeutics files for a $75m IPO to compete with Vertex Pharmaceuticals

ADVERTISEMENT